AstraZeneca Pharma India Limited — Important, 11-07-2025: Disclosure of material issue

AstraZeneca Pharma India has announced an ESG rating of 67 assigned by NSE Sustainability based on publicly available data for FY24. The company did not commission this rating and is currently reviewing the report. This independent ESG score could influence investor perception on sustainability credentials, but the company is assessing the findings before any further action.